| Phenotypic analysis of antigen-specific T lymphocytes JD Altman, PAH Moss, PJR Goulder, DH Barouch, ... Science 274 (5284), 94-96, 1996 | 4693 | 1996 |
| An immunogenic personal neoantigen vaccine for patients with melanoma PA Ott, Z Hu, DB Keskin, SA Shukla, J Sun, DJ Bozym, W Zhang, A Luoma, ... Nature 547 (7662), 217-221, 2017 | 2535 | 2017 |
| Safety and efficacy of single-dose Ad26. COV2. S vaccine against Covid-19 J Sadoff, G Gray, A Vandebosch, V Cárdenas, G Shukarev, B Grinsztejn, ... New England Journal of Medicine 384 (23), 2187-2201, 2021 | 2455 | 2021 |
| Interim results of a phase 1–2a trial of Ad26. COV2. S Covid-19 vaccine J Sadoff, M Le Gars, G Shukarev, D Heerwegh, C Truyers, AM de Groot, ... New England Journal of Medicine 384 (19), 1824-1835, 2021 | 1209 | 2021 |
| DNA vaccine protection against SARS-CoV-2 in rhesus macaques J Yu, LH Tostanoski, L Peter, NB Mercado, K McMahan, SH Mahrokhian, ... Science 369 (6505), 806-811, 2020 | 1120 | 2020 |
| Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination DH Barouch, S Santra, JE Schmitz, MJ Kuroda, TM Fu, W Wagner, ... Science 290 (5491), 486-492, 2000 | 1096 | 2000 |
| Correlates of protection against SARS-CoV-2 in rhesus macaques K McMahan, J Yu, NB Mercado, C Loos, LH Tostanoski, A Chandrashekar, ... Nature 590 (7847), 630-634, 2021 | 1073 | 2021 |
| Potently neutralizing and protective human antibodies against SARS-CoV-2 SJ Zost, P Gilchuk, JB Case, E Binshtein, RE Chen, JP Nkolola, A Schäfer, ... Nature 584 (7821), 443-449, 2020 | 1054 | 2020 |
| Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques NB Mercado, R Zahn, F Wegmann, C Loos, A Chandrashekar, J Yu, J Liu, ... Nature 586 (7830), 583-588, 2020 | 960 | 2020 |
| SARS-CoV-2 infection protects against rechallenge in rhesus macaques A Chandrashekar, J Liu, AJ Martinot, K McMahan, NB Mercado, L Peter, ... Science 369 (6505), 812-817, 2020 | 929 | 2020 |
| Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes DH Barouch, J Kunstman, MJ Kuroda, JE Schmitz, S Santra, FW Peyerl, ... Nature 415 (6869), 335-339, 2002 | 871 | 2002 |
| Animal models for COVID-19 C Muñoz-Fontela, WE Dowling, SGP Funnell, PS Gsell, AX Riveros-Balta, ... Nature 586 (7830), 509-515, 2020 | 798 | 2020 |
| Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys DH Barouch, JB Whitney, B Moldt, F Klein, TY Oliveira, J Liu, ... Nature 503 (7475), 224-228, 2013 | 789 | 2013 |
| Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys JB Whitney, AL Hill, S Sanisetty, P Penaloza-MacMaster, J Liu, M Shetty, ... Nature 512 (7512), 74-77, 2014 | 718 | 2014 |
| Adenovirus serotype 5 hexon mediates liver gene transfer SN Waddington, JH McVey, D Bhella, AL Parker, K Barker, H Atoda, ... Cell 132 (3), 397-409, 2008 | 701 | 2008 |
| Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients AS Iyer, FK Jones, A Nodoushani, M Kelly, M Becker, D Slater, R Mills, ... Science immunology 5 (52), eabe0367, 2020 | 678 | 2020 |
| Challenges in the development of an HIV-1 vaccine DH Barouch Nature 455 (7213), 613-619, 2008 | 615 | 2008 |
| Vaccine protection against Zika virus from Brazil RA Larocca, P Abbink, JPS Peron, PM de A. Zanotto, MJ Iampietro, ... Nature 536 (7617), 474-478, 2016 | 595 | 2016 |
| Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity DM Roberts, A Nanda, MJE Havenga, P Abbink, DM Lynch, BA Ewald, ... Nature 441 (7090), 239-243, 2006 | 581 | 2006 |
| Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D P Abbink, AAC Lemckert, BA Ewald, DM Lynch, M Denholtz, S Smits, ... Journal of virology 81 (9), 4654-4663, 2007 | 574 | 2007 |
